Actively Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Led by GlaxoSmithKline · Updated on 2026-01-23
892
Participants Needed
266
Research Sites
399 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon cancer.
CONDITIONS
Official Title
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Has untreated pathologically confirmed colon adenocarcinoma
- Has resectable colon adenocarcinoma defined as clinically T4N0 or Stage III
- Has radiologically evaluable disease
- Has a tumor demonstrating the presence of either dMMR status or MSI-H
You will not qualify if you...
- Has distant metastatic disease
- Has received prior medical therapy (chemotherapy, immunotherapy, biologic, or targeted therapy), radiation therapy or surgery for current colon cancer
- Has a tumor causing symptomatic bowel obstruction or requiring urgent/emergent surgery at screening (except if obstruction relieved by diverting stoma)
- Has history of colonic obstruction treated with colonic stents
- Has undergone major surgery, open biopsy, or significant trauma within 28 days prior to randomization
- Has history of interstitial lung disease, pneumonitis, or radiation induced enteritis
- Has cirrhosis or unstable liver/biliary disease with ascites, encephalopathy, coagulopathy, hypoalbuminemia, varices, or jaundice
- Has history of allogenic stem cell or organ transplantation
- Is receiving any other anticancer or experimental therapy during the study intervention
- Is pregnant, breastfeeding, or plans to conceive during the study
- Has severe allergic reactions to chimeric, human or humanized antibodies, fusion proteins, dostarlimab, or components of FOLFOX or CAPEOX
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 266 locations
1
GSK Investigational Site
Tucson, Arizona, United States, 85715
Actively Recruiting
2
GSK Investigational Site
Los Angeles, California, United States, 90027
Actively Recruiting
3
GSK Investigational Site
New Haven, Connecticut, United States, 06520
Actively Recruiting
4
GSK Investigational Site
Washington D.C., District of Columbia, United States, 20010
Withdrawn
5
GSK Investigational Site
Deerfield Beach, Florida, United States, 33064
Withdrawn
6
GSK Investigational Site
Fort Lauderdale, Florida, United States, 33316
Withdrawn
7
GSK Investigational Site
Marietta, Georgia, United States, 30060
Withdrawn
8
GSK Investigational Site
Chicago, Illinois, United States, 60611
Actively Recruiting
9
GSK Investigational Site
Chicago, Illinois, United States, 60612
Actively Recruiting
10
GSK Investigational Site
Chicago, Illinois, United States, 60637
Withdrawn
11
GSK Investigational Site
Naperville, Illinois, United States, 60126
Actively Recruiting
12
GSK Investigational Site
Naperville, Illinois, United States, 60540
Actively Recruiting
13
GSK Investigational Site
Westwood, Kansas, United States, 66205
Actively Recruiting
14
GSK Investigational Site
Lexington, Kentucky, United States, 40503
Withdrawn
15
GSK Investigational Site
Louisville, Kentucky, United States, 40206
Withdrawn
16
GSK Investigational Site
Baton Rouge, Louisiana, United States, 70809
Withdrawn
17
GSK Investigational Site
Bethesda, Maryland, United States, 20817
Actively Recruiting
18
GSK Investigational Site
Ann Arbor, Michigan, United States, 48109
Withdrawn
19
GSK Investigational Site
Detroit, Michigan, United States, 48202
Actively Recruiting
20
GSK Investigational Site
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
21
GSK Investigational Site
Joplin, Missouri, United States, 64804
Withdrawn
22
GSK Investigational Site
St Louis, Missouri, United States, 63128
Withdrawn
23
GSK Investigational Site
St Louis, Missouri, United States, 63141
Withdrawn
24
GSK Investigational Site
Grand Island, Nebraska, United States, 68803
Actively Recruiting
25
GSK Investigational Site
Omaha, Nebraska, United States, 68130
Actively Recruiting
26
GSK Investigational Site
Omaha, Nebraska, United States, 68198
Withdrawn
27
GSK Investigational Site
Lebanon, New Hampshire, United States, 03756
Withdrawn
28
GSK Investigational Site
New York, New York, United States, 10028
Actively Recruiting
29
GSK Investigational Site
New York, New York, United States, 10469
Actively Recruiting
30
GSK Investigational Site
New York, New York, United States, 11042
Actively Recruiting
31
GSK Investigational Site
New York, New York, United States, 11967
Actively Recruiting
32
GSK Investigational Site
The Bronx, New York, United States, 10461
Actively Recruiting
33
GSK Investigational Site
Durham, North Carolina, United States, 27710
Actively Recruiting
34
GSK Investigational Site
Akron, Ohio, United States, 44304
Actively Recruiting
35
GSK Investigational Site
Cincinnati, Ohio, United States, 45220
Actively Recruiting
36
GSK Investigational Site
Cleveland, Ohio, United States, 44111
Withdrawn
37
GSK Investigational Site
Cleveland, Ohio, United States, 44142
Withdrawn
38
GSK Investigational Site
Cleveland, Ohio, United States, 44196
Withdrawn
39
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73104
Withdrawn
40
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73120
Withdrawn
41
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15212
Withdrawn
42
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57078
Actively Recruiting
43
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57105
Actively Recruiting
44
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57401
Actively Recruiting
45
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57501
Actively Recruiting
46
GSK Investigational Site
Dallas, Texas, United States, 75235
Withdrawn
47
GSK Investigational Site
Dallas, Texas, United States, 75390
Completed
48
GSK Investigational Site
Richmond, Virginia, United States, 23229
Actively Recruiting
49
GSK Investigational Site
Appleton, Wisconsin, United States, 54911
Actively Recruiting
50
GSK Investigational Site
Buenos Aires, Argentina, 1093
Actively Recruiting
51
GSK Investigational Site
Buenos Aires, Argentina, C1180AAX
Actively Recruiting
52
GSK Investigational Site
Buenos Aires, Argentina, C1181ACH
Actively Recruiting
53
GSK Investigational Site
Capital Federal, Argentina, C1426ANZ
Actively Recruiting
54
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina, C1431FWO
Completed
55
GSK Investigational Site
Córdoba, Argentina, 5000
Actively Recruiting
56
GSK Investigational Site
Mar del Plata, Argentina, 7600
Actively Recruiting
57
GSK Investigational Site
Rosario, Argentina, S2002
Actively Recruiting
58
GSK Investigational Site
San Miguel de Tucumán, Argentina, T4000IHE
Actively Recruiting
59
GSK Investigational Site
Santa Fe, Argentina, S3000FUJ
Actively Recruiting
60
GSK Investigational Site
Newcastle, New South Wales, Australia, 2298
Actively Recruiting
61
GSK Investigational Site
St Leonards, New South Wales, Australia, 2065
Withdrawn
62
GSK Investigational Site
Woolangabba, Queensland, Australia, 4102
Actively Recruiting
63
GSK Investigational Site
Heidelberg, Victoria, Australia, 3084
Actively Recruiting
64
GSK Investigational Site
Melbourne, Victoria, Australia, 3004
Withdrawn
65
GSK Investigational Site
Aalst, Belgium, 9300
Actively Recruiting
66
GSK Investigational Site
Brussels, Belgium, 1070
Actively Recruiting
67
GSK Investigational Site
Brussels, Belgium, 1200
Actively Recruiting
68
GSK Investigational Site
Edegem, Belgium, 2650
Actively Recruiting
69
GSK Investigational Site
Ghent, Belgium, 9000
Actively Recruiting
70
GSK Investigational Site
Leuven, Belgium, 3000
Actively Recruiting
71
GSK Investigational Site
Liège, Belgium, 4000
Actively Recruiting
72
GSK Investigational Site
Roeselare, Belgium, 8800
Actively Recruiting
73
GSK Investigational Site
Barretos, Brazil, 14784-400
Actively Recruiting
74
GSK Investigational Site
Belém, Brazil, 66.073-005
Actively Recruiting
75
GSK Investigational Site
Campo Grande, Brazil, 79002-061
Actively Recruiting
76
GSK Investigational Site
Lages, Brazil, 88501-001
Actively Recruiting
77
GSK Investigational Site
Natal, Brazil, 59075-740
Actively Recruiting
78
GSK Investigational Site
Porto Alegre, Brazil, 90610-000
Actively Recruiting
79
GSK Investigational Site
Salvador, Brazil, 40414-120
Actively Recruiting
80
GSK Investigational Site
São José do Rio Preto, Brazil, 15090-000
Actively Recruiting
81
GSK Investigational Site
São Paulo, Brazil, 01509-010
Actively Recruiting
82
GSK Investigational Site
São Paulo, Brazil, 04312903
Actively Recruiting
83
GSK Investigational Site
Teresina, Brazil, 64049-200
Actively Recruiting
84
GSK Investigational Site
Vitória, Brazil, 29043-260
Actively Recruiting
85
GSK Investigational Site
Edmonton, Alberta, Canada, T6G 1Z2
Withdrawn
86
GSK Investigational Site
Halifax, Nova Scotia, Canada, B3H 1V7
Actively Recruiting
87
GSK Investigational Site
Ottawa, Ontario, Canada, K1H 8L6
Actively Recruiting
88
GSK Investigational Site
Toronto, Ontario, Canada, M5G 2M9
Actively Recruiting
89
GSK Investigational Site
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
90
GSK Investigational Site
Beijing, China, 100036
Actively Recruiting
91
GSK Investigational Site
Beijing, China, 100083
Actively Recruiting
92
GSK Investigational Site
Beijing, China, 100730
Actively Recruiting
93
GSK Investigational Site
Changchun, China, 130021
Actively Recruiting
94
GSK Investigational Site
Changsha, China, 410013
Actively Recruiting
95
GSK Investigational Site
Chengdu, China, 610041
Actively Recruiting
96
GSK Investigational Site
Chongqing, China, 400042
Actively Recruiting
97
GSK Investigational Site
Chongqing, China, 400042
Actively Recruiting
98
GSK Investigational Site
Guangzhou, China, 510060
Actively Recruiting
99
GSK Investigational Site
Guangzhou, China, 510655
Actively Recruiting
100
GSK Investigational Site
Hangzhou, China, 310016
Actively Recruiting
101
GSK Investigational Site
Hangzhou, China, 310022
Actively Recruiting
102
GSK Investigational Site
Hangzhou, China, 311100
Actively Recruiting
103
GSK Investigational Site
Hangzhou, China
Actively Recruiting
104
GSK Investigational Site
Harbin, China, 150000
Actively Recruiting
105
GSK Investigational Site
Jinan, China, 250117
Actively Recruiting
106
GSK Investigational Site
Kunming, China, 650106
Actively Recruiting
107
GSK Investigational Site
Meizhou, China, 514700
Actively Recruiting
108
GSK Investigational Site
Nanchang, China, 330006
Actively Recruiting
109
GSK Investigational Site
Nanchang, China, 330029
Actively Recruiting
110
GSK Investigational Site
Shanghai, China, 200032
Actively Recruiting
111
GSK Investigational Site
Shanghai, China, 200032
Actively Recruiting
112
GSK Investigational Site
Shenzhen, China, 518036
Actively Recruiting
113
GSK Investigational Site
Taiyuan, China, 030013
Actively Recruiting
114
GSK Investigational Site
Tianjin, China, 300000
Actively Recruiting
115
GSK Investigational Site
Wuhan, China, 430030
Actively Recruiting
116
GSK Investigational Site
Xiamen, China, 361004
Actively Recruiting
117
GSK Investigational Site
Yangzhou, China, 225001
Actively Recruiting
118
GSK Investigational Site
Zhengzhou, China, 450052
Actively Recruiting
119
GSK Investigational Site
Hradec Králové, Czechia, 500 05
Actively Recruiting
120
GSK Investigational Site
Nový Jičín, Czechia, 741 01
Actively Recruiting
121
GSK Investigational Site
Prague, Czechia, 150 06
Actively Recruiting
122
GSK Investigational Site
Tallinn, Estonia, 11312
Actively Recruiting
123
GSK Investigational Site
Tallinn, Estonia, 13419
Actively Recruiting
124
GSK Investigational Site
Tartu, Estonia, 50501
Actively Recruiting
125
GSK Investigational Site
Helsinki, Finland, 00029
Actively Recruiting
126
GSK Investigational Site
Tampere, Finland, 33520
Actively Recruiting
127
GSK Investigational Site
Turku, Finland, 20521
Actively Recruiting
128
GSK Investigational Site
Lyon, France, 69008
Actively Recruiting
129
GSK Investigational Site
Marseille, France, 13385
Actively Recruiting
130
GSK Investigational Site
Nantes, France, 44093
Actively Recruiting
131
GSK Investigational Site
Paris, France, 75015
Actively Recruiting
132
GSK Investigational Site
Pessac, France, 33604
Actively Recruiting
133
GSK Investigational Site
Rennes, France, 35042
Actively Recruiting
134
GSK Investigational Site
Rouen, France, 76000
Completed
135
GSK Investigational Site
Saint-Priest-en-Jarez, France, 42270
Actively Recruiting
136
GSK Investigational Site
Suresnes, France, 92150
Actively Recruiting
137
GSK Investigational Site
Toulouse, France, 31059
Actively Recruiting
138
GSK Investigational Site
Villejuif, France, 94805
Actively Recruiting
139
GSK Investigational Site
Berlin, Germany, 13353
Actively Recruiting
140
GSK Investigational Site
Düsseldorf, Germany, 40225
Actively Recruiting
141
GSK Investigational Site
Frankfurt, Germany, 60488
Actively Recruiting
142
GSK Investigational Site
Halle, Germany, 06120
Withdrawn
143
GSK Investigational Site
Lübeck, Germany, 23562
Actively Recruiting
144
GSK Investigational Site
Mannheim, Germany, 68167
Actively Recruiting
145
GSK Investigational Site
München, Germany, 81377
Actively Recruiting
146
GSK Investigational Site
München, Germany, 81737
Actively Recruiting
147
GSK Investigational Site
Athens, Greece, 11528
Completed
148
GSK Investigational Site
Thessaloniki, Greece, 54639
Completed
149
GSK Investigational Site
Thessaloniki, Greece, 570 10
Completed
150
GSK Investigational Site
Bengaluru, Karnataka, India, 560076
Actively Recruiting
151
GSK Investigational Site
Ludhiana, Punjab, India, 141123
Actively Recruiting
152
GSK Investigational Site
Belagavi, India, 590010
Actively Recruiting
153
GSK Investigational Site
Hyderabad, India, 500034
Actively Recruiting
154
GSK Investigational Site
Nashik, India, 422002
Actively Recruiting
155
GSK Investigational Site
Pune, India, 411040
Actively Recruiting
156
GSK Investigational Site
Cagliari, Italy, 09042
Actively Recruiting
157
GSK Investigational Site
Genova, Italy, 16132
Actively Recruiting
158
GSK Investigational Site
Milan, Italy, 20162
Actively Recruiting
159
GSK Investigational Site
Naples, Italy, 80131
Actively Recruiting
160
GSK Investigational Site
Padova, Italy, 35128
Actively Recruiting
161
GSK Investigational Site
Pisa, Italy, 56126
Actively Recruiting
162
GSK Investigational Site
Reggio Emilia, Italy, 40123
Actively Recruiting
163
GSK Investigational Site
Roma, Italy, 00152
Actively Recruiting
164
GSK Investigational Site
Roma, Italy, 00168
Actively Recruiting
165
GSK Investigational Site
Rozzano MI, Italy, 20089
Actively Recruiting
166
GSK Investigational Site
Aichi, Japan, 464-8681
Actively Recruiting
167
GSK Investigational Site
Chiba, Japan, 277-8577
Actively Recruiting
168
GSK Investigational Site
Fukuoka, Japan, 812-8582
Actively Recruiting
169
GSK Investigational Site
Hokkaido, Japan, 060-8648
Actively Recruiting
170
GSK Investigational Site
Hyōgo, Japan, 650-0047
Withdrawn
171
GSK Investigational Site
Ibaraki, Japan, 309-1793
Actively Recruiting
172
GSK Investigational Site
Kanagawa, Japan, 216-8511
Actively Recruiting
173
GSK Investigational Site
Kanagawa, Japan, 232-0024
Actively Recruiting
174
GSK Investigational Site
Kyoto, Japan, 606-8507
Actively Recruiting
175
GSK Investigational Site
Okayama, Japan, 710-8602
Actively Recruiting
176
GSK Investigational Site
Osaka, Japan, 540-0006
Actively Recruiting
177
GSK Investigational Site
Osaka, Japan, 541-8567
Actively Recruiting
178
GSK Investigational Site
Osaka, Japan, 558-8558
Actively Recruiting
179
GSK Investigational Site
Osaka, Japan, 565-0871
Actively Recruiting
180
GSK Investigational Site
Osaka, Japan, 573-1191
Actively Recruiting
181
GSK Investigational Site
Shizuoka, Japan, 411-8777
Actively Recruiting
182
GSK Investigational Site
Tokyo, Japan, 104-0045
Actively Recruiting
183
GSK Investigational Site
Tokyo, Japan, 135-8550
Actively Recruiting
184
GSK Investigational Site
DF, Mexico, 14000
Actively Recruiting
185
GSK Investigational Site
Guadalajara, Mexico, 44280
Actively Recruiting
186
GSK Investigational Site
Guadalajara, Mexico, 44650
Completed
187
GSK Investigational Site
Mexico City, Mexico, 03100
Actively Recruiting
188
GSK Investigational Site
Oaxaca City, Mexico, 68020
Actively Recruiting
189
GSK Investigational Site
San Pedro Garza García, Mexico, 66220
Completed
190
GSK Investigational Site
Tijuana, Mexico, 22010
Actively Recruiting
191
GSK Investigational Site
Breda, Netherlands, 4818 CK
Actively Recruiting
192
GSK Investigational Site
Maastricht, Netherlands, 6229 HX
Actively Recruiting
193
GSK Investigational Site
Nijmegen, Netherlands, 6525 GA
Actively Recruiting
194
GSK Investigational Site
Utrecht, Netherlands, 3584 CX
Actively Recruiting
195
GSK Investigational Site
Bergen, Norway, 5021
Actively Recruiting
196
GSK Investigational Site
Kristiansand, Norway, 4604
Actively Recruiting
197
GSK Investigational Site
Lrenskog, Norway, 1474
Actively Recruiting
198
GSK Investigational Site
Oslo, Norway, 0407
Actively Recruiting
199
GSK Investigational Site
Stavanger, Norway, 4011
Actively Recruiting
200
GSK Investigational Site
Tromsø, Norway, 9019
Withdrawn
201
GSK Investigational Site
Punta Pacifica Panama City Panama, Panama
Actively Recruiting
202
GSK Investigational Site
Bydgoszcz, Poland, 85-048
Actively Recruiting
203
GSK Investigational Site
Warsaw, Poland, 02-034
Actively Recruiting
204
GSK Investigational Site
Almada, Portugal, 2805-267
Actively Recruiting
205
GSK Investigational Site
Coimbra, Portugal, 3000-075
Actively Recruiting
206
GSK Investigational Site
Lisbon, Portugal, 1649-035
Actively Recruiting
207
GSK Investigational Site
Daegu, South Korea, 41404
Actively Recruiting
208
GSK Investigational Site
Gyeonggi-do, South Korea, 463712
Actively Recruiting
209
GSK Investigational Site
Seoul, South Korea, 06351
Actively Recruiting
210
GSK Investigational Site
Seoul, South Korea, 06591
Actively Recruiting
211
GSK Investigational Site
Seoul, South Korea, 138-736
Actively Recruiting
212
GSK Investigational Site
Badajoz, Spain, 06080
Actively Recruiting
213
GSK Investigational Site
BaracaldoVizcaya, Spain, 48903
Actively Recruiting
214
GSK Investigational Site
Barcelona, Spain, 08026
Actively Recruiting
215
GSK Investigational Site
Barcelona, Spain, 08035
Actively Recruiting
216
GSK Investigational Site
Barcelona, Spain, 08036
Actively Recruiting
217
GSK Investigational Site
Córdoba, Spain, 14004
Actively Recruiting
218
GSK Investigational Site
Donostia / San Sebastian, Spain, 20080
Actively Recruiting
219
GSK Investigational Site
Elche Alicante, Spain, 03203
Actively Recruiting
220
GSK Investigational Site
Granada, Spain, 18014
Actively Recruiting
221
GSK Investigational Site
Jaén, Spain, 23007
Actively Recruiting
222
GSK Investigational Site
L'Hospitalet de Llobrega, Spain, 08908
Actively Recruiting
223
GSK Investigational Site
Las Palmas de Gran Canar, Spain, 35016
Actively Recruiting
224
GSK Investigational Site
Madrid, Spain, 28006
Actively Recruiting
225
GSK Investigational Site
Madrid, Spain, 28009
Actively Recruiting
226
GSK Investigational Site
Madrid, Spain, 28034
Actively Recruiting
227
GSK Investigational Site
Madrid, Spain, 28040
Actively Recruiting
228
GSK Investigational Site
Madrid, Spain, 28040
Actively Recruiting
229
GSK Investigational Site
Madrid, Spain, 28041
Actively Recruiting
230
GSK Investigational Site
Madrid, Spain, 28046
Actively Recruiting
231
GSK Investigational Site
Madrid, Spain, 28050
Actively Recruiting
232
GSK Investigational Site
Madrid, Spain, 28222
Actively Recruiting
233
GSK Investigational Site
Málaga, Spain, 29010
Actively Recruiting
234
GSK Investigational Site
Oviedo, Spain, 33011
Actively Recruiting
235
GSK Investigational Site
Pamplona, Spain, 31008
Actively Recruiting
236
GSK Investigational Site
Santander, Spain, 39011
Actively Recruiting
237
GSK Investigational Site
Seville, Spain, 41013
Actively Recruiting
238
GSK Investigational Site
Valencia, Spain, 46009
Actively Recruiting
239
GSK Investigational Site
Valencia, Spain, 46010
Actively Recruiting
240
GSK Investigational Site
Valencia, Spain, 46014
Actively Recruiting
241
GSK Investigational Site
Zaragoza, Spain, 50009
Actively Recruiting
242
GSK Investigational Site
Eskilstuna, Sweden, 63349
Withdrawn
243
GSK Investigational Site
Gothenburg, Sweden, SE-413 45
Actively Recruiting
244
GSK Investigational Site
Linköping, Sweden, SE-581 85
Actively Recruiting
245
GSK Investigational Site
Malmö, Sweden, 20502
Actively Recruiting
246
GSK Investigational Site
Stockholm, Sweden, 11219
Withdrawn
247
GSK Investigational Site
Stockholm, Sweden, 11883
Actively Recruiting
248
GSK Investigational Site
Uppsala, Sweden, SE-751 85
Actively Recruiting
249
GSK Investigational Site
Kaohsiung City, Taiwan, 833
Actively Recruiting
250
GSK Investigational Site
Tainan, Taiwan, 704
Actively Recruiting
251
GSK Investigational Site
Taipei, Taiwan, 100
Actively Recruiting
252
GSK Investigational Site
Taoyuan, Taiwan, 333
Actively Recruiting
253
GSK Investigational Site
Ankara, Turkey (Türkiye), 06010
Actively Recruiting
254
GSK Investigational Site
Ankara, Turkey (Türkiye), 06230
Actively Recruiting
255
GSK Investigational Site
Ankara, Turkey (Türkiye)
Actively Recruiting
256
GSK Investigational Site
Istanbul, Turkey (Türkiye), 34722
Actively Recruiting
257
GSK Investigational Site
Birmingham, United Kingdom, B9 5SS
Actively Recruiting
258
GSK Investigational Site
Chelmsford, United Kingdom, CM1 7ET
Actively Recruiting
259
GSK Investigational Site
Cheltenham, United Kingdom, GL53 7AN
Actively Recruiting
260
GSK Investigational Site
Edinburgh, United Kingdom, EH4 2XU
Actively Recruiting
261
GSK Investigational Site
Hull, United Kingdom, HU16 5JQ
Actively Recruiting
262
GSK Investigational Site
Leeds West Yorkshire, United Kingdom, LS9 7TF
Actively Recruiting
263
GSK Investigational Site
London, United Kingdom, NW3 2QG
Actively Recruiting
264
GSK Investigational Site
London, United Kingdom, SW3 6JJ
Actively Recruiting
265
GSK Investigational Site
Manchester, United Kingdom, M20 4BX
Actively Recruiting
266
GSK Investigational Site
Sutton, United Kingdom, SM2 5PT
Actively Recruiting
Research Team
U
US GSK Clinical Trials Call Center
CONTACT
E
EU GSK Clinical Trials Call Center
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here